Barinthus Biotherapeutics moves to deregister ADS under Exchange Act Section 12(g) - BRNS News | RalliesBarinthus Biotherapeutics moves to deregister ADS under Exchange Act Section 12(g)
B
BRNS• Barinthus Biotherapeutics files to terminate SEC registration
- Barinthus Biotherapeutics filed to terminate SEC registration of its American Depositary Shares, moving to deregister and delist the securities.
- Holder count for the American Depositary Shares stood at 1 as of the filing date.
- The termination notice was signed on Sept. 21, 2026.
•
